AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Claritev Corporation

$36.44 +$2.55 (+7.52%)
NYSE · 14 Sep 2026 20:00 UTC
Previous Close
$35.98
Day Range
$35.66$37.27
Year Range
$11.5$73.68
Market Cap
621.22M
AVG Volume
143.25K
Trailing/Forward PE
-2.14/-
PEG ratio
0.2
Dividend Yield
-
Next Earnings Date
2026-11-06
Primary Exchange
New York Stock ExchangeUS
Revenue (USD)
0100M200M300M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CTEV Revenue (USD) by quarter
PeriodRevenue (USD)
26 Q2257.48M
26 Q1244.68M
25 Q4246.55M
25 Q3245.96M
25 Q2241.57M
25 Q1231.33M
24 Q4232.15M
24 Q3230.5M
24 Q2233.48M
24 Q1234.51M
Net Income (USD)
-600M-400M-200M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CTEV Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q2-59.23M
26 Q1-73.56M
25 Q4-80.57M
25 Q3-69.75M
25 Q2-62.64M
25 Q1-71.32M
24 Q4-137.97M
24 Q3-391.45M
24 Q2-576.73M
24 Q1-539.69M
Operating Income (USD)
-600M-400M-200M0200M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CTEV Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q223.41M
26 Q16.68M
25 Q48.67M
25 Q310.07M
25 Q216.58M
25 Q19.74M
24 Q4-41.36M
24 Q3-338.21M
24 Q2-523.93M
24 Q1-486.44M
EBITDA (USD)
-600M-400M-200M0200M400M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CTEV EBITDA (USD) by quarter
PeriodEBITDA (USD)
26 Q2201.97M
26 Q1116.82M
25 Q4104.77M
25 Q3167.03M
25 Q2128.83M
25 Q1113.31M
24 Q44.9M
24 Q3-227.29M
24 Q2-414.27M
24 Q1-371.24M
Cash Flows (USD)
-100M-50M050M100M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CTEV Cash Flows (USD) by quarter
PeriodCash Flows (USD)
26 Q254.59M
26 Q1-92.55M
25 Q436.38M
25 Q3-16.35M
25 Q236.61M
25 Q1-68.92M
24 Q4-64.46M
24 Q341.14M
24 Q2-6.97M
24 Q119.17M
EPS (USD)
-40-30-20-10024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CTEV EPS (USD) by quarter
PeriodEPS (USD)
26 Q2-3.49
26 Q1-4.41
25 Q4-4.88
25 Q3-4.23
25 Q2-3.81
25 Q1-4.38
24 Q4-8.49
24 Q3-24.25
24 Q2-35.78
24 Q1-33.4
Expenses (USD)
050M100M150MSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CTEV Expenses (USD) by quarter
PeriodExpenses (USD)
26 Q293.47M
26 Q1104.6M
25 Q478.02M
25 Q384.21M
25 Q277.56M
25 Q189.5M
24 Q483.52M
24 Q369.42M
24 Q260M
24 Q165.4M
Cash & Debt (USD)
02B4B6BCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CTEV Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
26 Q214.37M
26 Q121.33M
25 Q416.81M
25 Q350.65M
25 Q256.39M
25 Q123.13M
24 Q416.85M
24 Q386.6M
24 Q248.77M
24 Q158.7M
Debt ratios
-100010020030024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CTEV Debt ratios by quarter
PeriodDebt ratios
26 Q27.8
26 Q18.87
25 Q48.98
25 Q311.11
25 Q2232.58
25 Q1-8.81
24 Q4-4.49
24 Q3-5.22
24 Q2-9.65
24 Q149.51
Margins
0%20%40%60%80%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CTEV Margins by quarter
PeriodMargins
26 Q29.09%
26 Q126.36%
25 Q468.35%
25 Q374.77%
25 Q274.82%
25 Q173.87%
24 Q475.39%
24 Q373.61%
24 Q273.72%
24 Q174.38%
Return on Capital
-600%-400%-200%0%200%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CTEV Return on Capital by quarter
PeriodReturn on Capital
26 Q220.58%
26 Q131.38%
25 Q448.2%
25 Q368.5%
25 Q2156.96%
25 Q1-481.07%
24 Q4-164.2%
24 Q3-188.59%
24 Q2-95.59%
24 Q1-46.11%
Shares Outstanding
05M10M15M20M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CTEV Shares Outstanding by quarter
PeriodShares Outstanding
26 Q216.96M
26 Q116.69M
25 Q416.43M
25 Q316.48M
25 Q216.45M
25 Q116.27M
24 Q416.15M
24 Q316.14M
24 Q216.12M
24 Q116.16M
Book Value Per Share (USD)
-25025507524 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CTEV Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
26 Q2-16.97
26 Q1-14.04
25 Q4-10.17
25 Q3-6.18
25 Q2-2.43
25 Q10.91
24 Q45.2
24 Q312.86
24 Q237.44
24 Q172.43
Total Assets (USD)
02B4B6B8B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CTEV Total Assets (USD) by quarter
PeriodTotal Assets (USD)
26 Q24.76B
26 Q14.84B
25 Q44.89B
25 Q34.99B
25 Q25.07B
25 Q15.08B
24 Q45.15B
24 Q35.32B
24 Q25.74B
24 Q16.37B
Employee Count
01K2K3K4K2025
CTEV Employee Count by quarter
PeriodEmployee Count
20253K
Free Cash Flow Yield
-40%-20%0%20%med -6.6%May 25Jul 25Oct 25Jan 26Apr 26Jun 26Sep 26
CTEV Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-2.9%
Sep 26-2.94%
Sep 26-2.75%
Aug 26-2.68%
Aug 26-2.83%
Aug 26-2.77%
Aug 26-3.24%
Jul 26-9.47%
Jul 26-9.95%
Jul 26-7.08%
Jul 26-6.88%
Jul 26-6.59%
Jun 26-6.49%
Jun 26-7.31%
Jun 26-6.96%
Jun 26-8.32%
May 26-8.56%
May 26-9.92%
May 26-15.51%
May 26-7.97%
May 26-3%
Apr 26-3.14%
Apr 26-3.63%
Apr 26-4.6%
Apr 26-4.28%
Mar 26-4.81%
Mar 26-5.02%
Mar 26-4.42%
Mar 26-4.34%
Feb 26-5.55%
Feb 26-29.5%
Feb 26-29.85%
Feb 26-26.49%
Jan 26-25.27%
Jan 26-23.78%
Jan 26-22.55%
Jan 26-23.72%
Jan 26-20.25%
Dec 25-16.33%
Dec 25-16.73%
Dec 25-18.33%
Dec 25-20.22%
Nov 25-12.69%
Nov 25-14.57%
Nov 25-15.87%
Nov 25-9.91%
Oct 25-5.19%
Oct 25-4.85%
Oct 25-6.12%
Oct 25-6.29%
Oct 25-6.62%
Sep 25-6.57%
Sep 25-6.54%
Sep 25-5.5%
Sep 25-4.84%
Aug 25-4.91%
Aug 25-4.69%
Aug 25-4.72%
Aug 25-5.95%
Aug 25-15.84%
Jul 25-15.37%
Jul 25-14.28%
Jul 25-13.16%
Jul 25-13.42%
Jun 25-13.99%
Jun 25-15.24%
Jun 25-16.43%
Jun 25-15.41%
May 25-15.86%
May 25-22.96%
May 25-22.27%
May 25-28.14%
May 25-3.08%
Apr 25-3%
Apr 25-3.43%
Apr 25-3.39%
Apr 25-3.44%
Mar 25-3.32%
Mar 25-3.27%
Mar 25-3.44%
Mar 25-3.77%
Feb 2514.67%
Price to Sales
00.511.5med 0.54May 25Jul 25Oct 25Jan 26Apr 26Jun 26Sep 26
CTEV Price to Sales by quarter
PeriodPrice to Sales
Sep 260.62
Sep 260.61
Sep 260.66
Aug 260.67
Aug 260.64
Aug 260.65
Aug 260.56
Jul 260.39
Jul 260.37
Jul 260.52
Jul 260.53
Jul 260.56
Jun 260.57
Jun 260.5
Jun 260.53
Jun 260.44
May 260.43
May 260.37
May 260.24
May 260.46
May 260.42
Apr 260.41
Apr 260.35
Apr 260.28
Apr 260.3
Mar 260.26
Mar 260.25
Mar 260.29
Mar 260.29
Feb 260.23
Feb 260.4
Feb 260.4
Feb 260.45
Jan 260.47
Jan 260.5
Jan 260.53
Jan 260.5
Jan 260.59
Dec 250.73
Dec 250.71
Dec 250.65
Dec 250.59
Nov 250.94
Nov 250.82
Nov 250.75
Nov 251.2
Oct 251.14
Oct 251.23
Oct 250.97
Oct 250.94
Oct 250.9
Sep 250.9
Sep 250.91
Sep 251.08
Sep 251.23
Aug 251.21
Aug 251.27
Aug 251.26
Aug 251
Aug 250.68
Jul 250.7
Jul 250.75
Jul 250.81
Jul 250.8
Jun 250.76
Jun 250.7
Jun 250.65
Jun 250.69
May 250.67
May 250.47
May 250.48
May 250.38
May 250.39
Apr 250.4
Apr 250.35
Apr 250.35
Apr 250.35
Mar 250.36
Mar 250.37
Mar 250.35
Mar 250.32
Feb 250.36
EV/EBITDA
0100200300med 9.94Sep 25Nov 25Jan 26Mar 26May 26Jul 26Sep 26
CTEV EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 268.85
Sep 268.83
Sep 268.91
Aug 268.93
Aug 268.87
Aug 268.9
Aug 268.74
Jul 269.6
Jul 269.56
Jul 269.85
Jul 269.87
Jul 269.92
Jun 269.94
Jun 269.81
Jun 269.86
Jun 269.7
May 269.68
May 269.56
May 269.31
May 269.74
May 269.78
Apr 269.74
Apr 269.64
Apr 269.5
Apr 269.54
Mar 269.48
Mar 269.46
Mar 269.52
Mar 269.53
Feb 269.41
Feb 2612.04
Feb 2612.03
Feb 2612.15
Jan 2612.19
Jan 2612.26
Jan 2612.33
Jan 2612.27
Jan 2612.46
Dec 2512.79
Dec 2512.75
Dec 2512.6
Dec 2512.47
Nov 2513.27
Nov 2512.99
Nov 2512.84
Nov 2513.87
Oct 25286.82
Oct 25290.65
Oct 25278.63
Oct 25277.35
Oct 25275.15
Sep 25275.45
Sep 25275.68
Sep 25283.81
Sep 25290.76
Aug 25290
Aug 25292.71
Aug 25292.25
Aug 25279.92
Price/Operating Cashflow
020406080med 12.05May 25Jul 25Oct 25Jan 26Apr 26Jun 26Sep 26
CTEV Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 264.65
Sep 264.59
Sep 264.9
Aug 265.02
Aug 264.75
Aug 264.86
Aug 264.16
Jul 263.73
Jul 263.55
Jul 264.99
Jul 265.13
Jul 265.36
Jun 265.45
Jun 264.83
Jun 265.08
Jun 264.25
May 264.13
May 263.56
May 262.28
May 264.44
May 263.49
Apr 263.34
Apr 262.88
Apr 262.27
Apr 262.45
Mar 262.18
Mar 262.09
Mar 262.37
Mar 262.41
Feb 261.89
Feb 2622.55
Feb 2622.27
Feb 2625.1
Jan 2626.31
Jan 2627.96
Jan 2629.49
Jan 2628.04
Jan 2632.84
Dec 2540.72
Dec 2539.74
Dec 2536.28
Dec 2532.89
Nov 2552.39
Nov 2545.65
Nov 2541.91
Nov 2567.1
Oct 2515.3
Oct 2516.38
Oct 2512.99
Oct 2512.63
Oct 2512.01
Sep 2512.09
Sep 2512.16
Sep 2514.45
Sep 2516.41
Aug 2516.2
Aug 2516.96
Aug 2516.83
Aug 2513.35
Aug 2523
Jul 2523.71
Jul 2525.52
Jul 2527.68
Jul 2527.15
Jun 2526.04
Jun 2523.91
Jun 2522.18
Jun 2523.64
May 2522.98
May 2515.87
May 2516.36
May 2512.95
May 253.37
Apr 253.47
Apr 253.03
Apr 253.07
Apr 253.02
Mar 253.13
Mar 253.18
Mar 253.03
Mar 252.76
Feb 252.01
Price to Book
0204060med 29.15Mar 25Apr 25May 25Jun 25Jul 25Aug 25
CTEV Price to Book by quarter
PeriodPrice to Book
Aug 2542.24
Jul 2543.56
Jul 2546.88
Jul 2550.84
Jul 2549.87
Jun 2547.84
Jun 2543.91
Jun 2540.73
Jun 2543.42
May 2542.21
May 2529.15
May 2530.05
May 2523.79
May 254.3
Apr 254.42
Apr 253.86
Apr 253.91
Apr 253.85
Mar 253.99
Mar 254.05
Mar 253.85
Mar 253.51
Feb 251.63
Claritev Corporation
CTEV
Stockpicker

Video analysis: CTEV

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: CTEV

Claritev Cares Helps Rural Patients Get Critical Care Closer to Home

businesswire.com · 10 Sep 2026

Claritev Cares Helps Rural Patients Get Critical Care Closer to Home

MCLEAN, Va.--(BUSINESS WIRE)---- $CTEV #ClaritevCares--Claritev Corporation (NYSE: CTEV), a healthcare technology, data, and insights company focused on making healthcare more affordable and transparent for all, today announced that Claritev Cares, its nonprofit foundation focused on expanding access to healthcare, has awarded its 2026 Rural Health Grants to Fairfield Memorial Hospital in Fairfield, Illinois, and Kodiak Community Health Center in Kodiak, Alaska. The grants will help address two very real barriers to ru.

Claritev Corporation Announces Participation in Upcoming Events

businesswire.com · 27 Aug 2026

Claritev Corporation Announces Participation in Upcoming Events

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a healthcare technology, data, and insights company, today announced that members of its management team will meet with investors at the following events in September 2026: Wells Fargo 21st Annual Healthcare Conference – Wednesday, September 9, 2026, at the Encore Boston Harbor – one-on-one meetings J.P. Morgan 4th Annual Healthcare Credit Conference - Thursday, September 10, 2026, at The Joseph Nashv.

Marpai Expands Relationship with Claritev to Help Reduce Healthcare Costs for Employer Clients

businesswire.com · 17 Aug 2026

Marpai Expands Relationship with Claritev to Help Reduce Healthcare Costs for Employer Clients

MCLEAN, Va.--(BUSINESS WIRE)---- $CTEV #ClaimsManagement--Claritev Corporation (NYSE: CTEV), a healthcare technology, data, and insights company, today announced that Marpai, Inc. (OTCQX: MRAI) has expanded its relationship with Claritev to bring comprehensive pre- and post-payment integrity capabilities to the health plans and claims it administers. Marpai currently uses Claritev's PHCS® Network to provide access to healthcare providers and negotiated rates outside its clients' primary networks. The expanded agreement ex.

Claritev Analysts Raise Their Forecasts Following Q2 Earnings

benzinga.com · 10 Aug 2026

Claritev Analysts Raise Their Forecasts Following Q2 Earnings

Claritev Corp (NYSE:CTEV) on Friday reported better-than-expected second-quarter financial results and raised its FY26 sales guidance above estimates.

Claritev Q2 Earnings Call Highlights

marketbeat.com · 7 Aug 2026

Claritev Q2 Earnings Call Highlights

Claritev NYSE: CTEV reported second-quarter revenue growth, record bookings and higher cash flow, prompting the healthcare technology company to raise its full-year revenue, adjusted EBITDA and free-cash-flow outlook.

Claritev Corporation (CTEV) Q2 2026 Earnings Call Transcript

seekingalpha.com · 7 Aug 2026

Claritev Corporation (CTEV) Q2 2026 Earnings Call Transcript

Claritev Corporation (CTEV) Q2 2026 Earnings Call Transcript

Claritev Corporation (CTEV) Reports Q2 Loss, Tops Revenue Estimates

zacks.com · 7 Aug 2026

Claritev Corporation (CTEV) Reports Q2 Loss, Tops Revenue Estimates

Claritev Corporation (CTEV) came out with a quarterly loss of $3.49 per share versus the Zacks Consensus Estimate of a loss of $4.1. This compares to earnings of $0.32 per share a year ago.

Claritev Corporation Reports Second Quarter 2026 Results

businesswire.com · 7 Aug 2026

Claritev Corporation Reports Second Quarter 2026 Results

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the second quarter ended June 30, 2026. “Claritev once again demonstrated the strength of our vision and strategy in the second quarter of 2026, delivering financial results above expectations with solid execution across the company. We are one year i.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.